Carl Schneider

March 10, 2021

Opioid script changes mean well, but have left some people in chronic pain

Aili Langford, University of Sydney; Carl Schneider, University of Sydney; Christine Lin, University of Sydney, and Danijela Gnjidic, University of Sydney

A one-dimensional approach to reducing opioid use isn’t favoured by health care professionals or patients.

February 11, 2020

Instant prescriptions might be the way of our digital future, but we need to manage the risks first

Jonathan Penm, University of Sydney; Andrew McLachlan, University of Sydney; Carl Schneider, University of Sydney, and Tim Usherwood, University of Sydney

The convenience of digital consultations can be compelling. But these services aren’t without risk – especially when people don’t interact directly with a health-care professional.

March 27, 2019

Making more drugs available ‘over the counter’ would be a win for the public and the health care system

Jack Collins, University of Sydney; Andrew McLachlan, University of Sydney; Carl Schneider, University of Sydney; Rebekah Moles, University of Sydney, and Stephen Carter, University of Sydney

A greater number of medicines may soon be available without a prescription. Under the right circumstances, this would mean you could bypass the doctor and access the treatments you need more quickly.

September 14, 2018

New law won’t safeguard medicine supply – it’ll only ensure we know there’s a shortage

Stephen Carter, University of Sydney; Carl Schneider, University of Sydney, and Rebekah Moles, University of Sydney

Recently passed legislation will ensure pharmaceutical companies report shortages of medicines. This is only about notifications. It won’t prevent medicine shortages themselves.